For help on how to get the results you want, see our search tips.
5 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral type
Articles 39 and 40 Remove Articles 39 and 40 filter
Article 13 Remove Article 13 filter
Article 31 referrals Remove Article 31 referrals filter
Article 20 procedures Remove Article 20 procedures filter
Referral status
Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter
Under evaluation Remove Under evaluation filter
Categories
Human Remove Human filter
-
List item
Referral: Synchron (updated)
Article 31 referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 19/05/2022, Last updated: 24/06/2022 -
List item
Referral: Rubraca (updated)
rucaparib, associated names: Rubraca, Article 20 procedures
Status: Under evaluation, Last updated: 24/06/2022 -
List item
Referral: Janus Kinase inhibitors (JAKi) (updated)
tofacitinib, abrocitinib, baricitinib, upadacitinib, filgotinib, associated names: Xeljanz, Cibinqo, Olumiant, Rinvoq, Jyseleca, Article 20 procedures
Status: Under evaluation, Last updated: 13/06/2022 -
List item
Referral: Terlipressin-containing medicinal products indicated in the treatment of hepatorenal syndrome (updated)
terlipressin, Article 31 referrals
Status: Under evaluation, Last updated: 10/06/2022 -
List item
Referral: Nomegestrol and chlormadinone
nomegestrol, chlormadinone, associated names: Zoely, Article 31 referrals
Status: Under evaluation, Last updated: 10/05/2022